Table 3.
Multivariate analyses of the OS and DFS of hepatocellular carcinoma patients according to clinical characteristics and immune scores.
| Characteristics | OS | DFS | ||
|---|---|---|---|---|
| HR (95% CI) | p | HR (95% CI) | p | |
| Age (years) | ||||
| ≤30 | 1.000 | 1.000 | ||
| 31-40 | 2.733 (0.299, 25.008) | 0.373 | 0.549 (0.215, 1.403) | 0.210 |
| 41-50 | 3.054 (0.373, 25.009) | 0.298 | 0.397 (0.170, 0.930) | 0.033 |
| 51-60 | 3.338 (0.440, 25.321) | 0.244 | 0.507 (0.240, 1.067) | 0.074 |
| 61-70 | 2.427 (0.317, 18.607) | 0.394 | 0.456 (0.218, 0.952) | 0.037 |
| 71-80 | 4.465 (0.577, 34.578) | 0.152 | 0.582 (0.262, 1.291) | 0.183 |
| >80 | 5.027 (0.290, 87.030) | 0.267 | 0.393 (0.080, 1.927) | 0.249 |
| Stage | ||||
| I | 1.000 | 1.000 | ||
| II | 1.332 (0.641, 2.768) | 0.443 | 2.078 (1.396, 3.095) | <0.001 |
| III | 4.218 (2.397, 7.421) | <0.001 | 2.717 (1.854, 3.981) | <0.001 |
| IV | 13.552 (2.939, 62.485) | 0.001 | 7.634 (2.246, 25.951) | 0.001 |
| Immune score | ||||
| Low | 1.000 | 1.000 | ||
| Medium | 0.417 (0.186, 0.937) | 0.034 | 0.575 (0.329, 1.004) | 0.052 |
| High | 0.299 (0.146, 0.616) | 0.001 | 0.451 (0.278, 0.733) | 0.001 |